AC
IONS icon

AXQ Capital’s Ionis Pharmaceuticals IONS Stock Holding History

AXQ Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$826K Buy
10,423
+6,577
+171% +$495K 0.09% 334
2026
Q1 		$289K Buy
+3,846
New +$304K 0.04% 612
2025
Q2 		– Sell
-30,104
Closed -$908K – 665
2025
Q1 		$908K Buy
+30,104
New +$986K 0.36% 70

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

AXQ Capital's IONS Position: Q2 2026 in Review

AXQ Capital increased its Ionis Pharmaceuticals (IONS) stake by 171% in Q2 2026, buying an estimated $495K and bringing the position to 10,423 shares worth $826K. The position accounts for 0.09% of the portfolio, ranked #334.

AXQ Capital first reported a position in IONS in Q1 2025 and has held it in 3 quarters since. The position peaked at $908K in Q1 2025. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • AXQ Capital held 10,423 shares of Ionis Pharmaceuticals worth $826K as of Q2 2026.
  • AXQ Capital bought 6,577 Ionis Pharmaceuticals shares in Q2 2026, an estimated $495K.
  • Ionis Pharmaceuticals made up 0.09% of AXQ Capital's portfolio in Q2 2026, its #334 holding.
  • AXQ Capital first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • AXQ Capital's Ionis Pharmaceuticals position peaked at $908K in Q1 2025.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.